Park et al., 2019 - Google Patents
Novel interface for high-throughput analysis of biotherapeutics by electrospray mass spectrometryPark et al., 2019
View HTML- Document ID
- 13974767921951967402
- Author
- Park H
- Winton V
- Drader J
- Manalili Wheeler S
- Lazar G
- Kelleher N
- Liu Y
- Tran J
- Compton P
- Publication year
- Publication venue
- Analytical chemistry
External Links
Snippet
With the rapid rise of therapeutic antibodies and antibody-drug conjugates, significant investments have been made in developing workflows that utilize mass spectrometry to detect these intact molecules, the large fragments generated by their selective digestion …
- 238000002330 electrospray ionisation mass spectrometry 0 title abstract description 29
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/38—Flow patterns
- G01N30/46—Flow patterns using more than one column
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N2030/022—Column chromatography characterised by the kind of separation mechanism
- G01N2030/027—Liquid chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/86—Signal analysis
- G01N30/8665—Signal analysis for calibrating the measuring apparatus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Park et al. | Novel interface for high-throughput analysis of biotherapeutics by electrospray mass spectrometry | |
Fornelli et al. | Middle-down analysis of monoclonal antibodies with electron transfer dissociation orbitrap fourier transform mass spectrometry | |
Mao et al. | Top-down structural analysis of an intact monoclonal antibody by electron capture dissociation-Fourier transform ion cyclotron resonance-mass spectrometry | |
Bern et al. | Parsimonious charge deconvolution for native mass spectrometry | |
Ehkirch et al. | An online four-dimensional HIC× SEC-IM× MS methodology for proof-of-concept characterization of antibody drug conjugates | |
Fekete et al. | Chromatographic, electrophoretic, and mass spectrometric methods for the analytical characterization of protein biopharmaceuticals | |
Cotham et al. | Characterization of therapeutic monoclonal antibodies at the subunit-level using middle-down 193 nm ultraviolet photodissociation | |
Wei et al. | Native hydrophobic interaction chromatography hyphenated to mass spectrometry for characterization of monoclonal antibody minor variants | |
Tsybin et al. | Structural analysis of intact monoclonal antibodies by electron transfer dissociation mass spectrometry | |
Proc et al. | A quantitative study of the effects of chaotropic agents, surfactants, and solvents on the digestion efficiency of human plasma proteins by trypsin | |
Kalli et al. | Evaluation and optimization of mass spectrometric settings during data-dependent acquisition mode: focus on LTQ-Orbitrap mass analyzers | |
MacLean et al. | Effect of collision energy optimization on the measurement of peptides by selected reaction monitoring (SRM) mass spectrometry | |
Gargano et al. | Capillary HILIC-MS: a new tool for sensitive top-down proteomics | |
Razavi et al. | High-throughput SISCAPA quantitation of peptides from human plasma digests by ultrafast, liquid chromatography-free mass spectrometry | |
Chen et al. | Improved host cell protein analysis in monoclonal antibody products through molecular weight cutoff enrichment | |
Nicolardi et al. | Structural analysis of an intact monoclonal antibody by online electrochemical reduction of disulfide bonds and Fourier transform ion cyclotron resonance mass spectrometry | |
Campuzano et al. | Denaturing and native mass spectrometric analytics for biotherapeutic drug discovery research: historical, current, and future personal perspectives | |
Zhao et al. | Compact ultrahigh-pressure nanoflow capillary liquid chromatograph | |
Wang et al. | Enhanced-fluidity liquid chromatography–mass spectrometry for intact protein separation and characterization | |
D’Atri et al. | Orthogonal middle-up approaches for characterization of the glycan heterogeneity of etanercept by hydrophilic interaction chromatography coupled to high-resolution mass spectrometry | |
Kellie et al. | Intact protein mass spectrometry for therapeutic protein quantitation, pharmacokinetics, and biotransformation in preclinical and clinical studies: an industry perspective | |
Levy et al. | Probing the sensitivity of the orbitrap lumos mass spectrometer using a standard reference protein in a complex background | |
Butler et al. | High-resolution demultiplexing (HRdm) ion mobility spectrometry–mass spectrometry for aspartic and isoaspartic acid determination and screening | |
Campuzano et al. | High mass analysis with a fourier transform ion cyclotron resonance mass spectrometer: from inorganic salt clusters to antibody conjugates and beyond | |
Ayoub et al. | Characterization of the N-terminal heterogeneities of monoclonal antibodies using in-gel charge derivatization of α-amines and LC-MS/MS |